FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to the chemical-pharmaceutical industry and represents a compound having a structure according to formula I:
,
compositions containing the compounds of the above formula applicable to stimulate neurogenesis and/or inhibition of neuron degeneration.
EFFECT: invention may be used in treating diseases and conditions characterised by neuron loss and lower neurogenesis, including Alzheimer's disease, stroke, traumatic brain injury, traumatic nerve injury and depression.
8 cl, 2 tbl, 2 ex, 1 dwg
Authors
Dates
2014-06-27—Published
2008-06-20—Filed